This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
7 Citations 5 Q&As
9 Citations 1 Q&As
2 Citations
Facts about Annexin A5.
Human | |
---|---|
Gene Name: | ANXA5 |
Uniprot: | P08758 |
Entrez: | 308 |
Belongs to: |
---|
annexin family |
Anchorin CII; annexin A5; Annexin V; annexin-5; ANX5; ANXA5; ANXV; Calphobindin I; Endonexin II; ENX2CBP-I; Lipocortin V; PAP-I; Placental anticoagulant protein 4; Placental anticoagulant protein I; PP4; Thromboplastin inhibitor; VAC-alpha; Vascular anticoagulant-alpha
Mass (kDA):
35.937 kDA
Human | |
---|---|
Location: | 4q27 |
Sequence: | 4; NC_000004.12 (121667946..121696994, complement) |
It is essential to optimize your research when using the Boster Bio. The optimization tips and guides that come with this reagent can help you optimize your experiment and improving results. Even with the best control methods, experiments are likely to have issues. Troubleshooting guides will help you isolate potential sources of error and provide solutions. You'll be able obtain better results than you'd imagined.
The ANXA5 gene is many potential uses in research. It is an important marker for studying gene expression in the heart, brain, and intestine. Boster Bio offers high affinity primary antibodies for this gene. They are validated on immunohistochemistry, Western blotting, and ELISA. These antibodies have been extensively used in research for a long time and are frequently referenced in scientific publications.
ANXA5 plays a significant role in the development of ectopic epimetriosis. It is associated with a high E2 concentration and is a marker of tumor metastasis. However, the molecular factors that play a role in the pathogenesis of adenomyosis remain elusive. However the ANXA5 gene has been proven to play an important part in regulating the epithelial to mesenchymal transition.
E2-induced up-regulation of ANXA2 is also linked to reduced expression of E-cadherin as well as the increase in vimentin and slug. This gene can be used in research to understand EMT and its potential therapeutic benefits. This marker is able to be used to detect Adenomyosis, an important step in the treatment of cancer. Because it blocks EMT and thereby reducing the risk of cancer, it is a promising tool for treating cancer.
Although this gene has numerous applications, the most significant one is that it lets doctors determine whether or not an individual suffers from endometriosis. The high levels of this gene is associated with the risk of recurrent endomyosis. The ectopic part of the endometrium also contains the protein. The ectopic uterus has an increased level of ANXA2 expression than eutopic endometrium.
AnxA2 plays an important role in adenomyosis pathogenesis. Aiming at patients suffering from this gene could be a promising treatment strategy. It is important that we understand the role of the ANXA2 gene in the development of adenomyosis. This gene will continue to be a valuable tool in the treatment of this disease.
One study showed that ANXA2-expressing cell lines showed higher the chemotactic activity as well as morphological differentiation in the adenomyosis. The development of blood vessels in newborns was also affected by the ANXA2 gene. In an alginate-encapsulated cell assay, ANXA2 shRNA inhibited the HIF-1a pathway and activated the VEGF-A pathway.
Boster Bio's Anti Annexin V/ANXA5 antibody reacts with Human, Mouse and Rat Annexin V. By using this antibody, researchers can determine the presence of ANXA5 and other genes present in their samples. These anti-annexin V antibodies can be used in various applications for tissue culture, cell culture , and other biomedical research.
PMID: 2964863 by Funakoshi T., et al. Primary structure of human placental anticoagulant protein.
PMID: 2963810 by Iwasaki A., et al. Structure and expression of cDNA for an inhibitor of blood coagulation isolated from human placenta: a new lipocortin-like protein.
*More publications can be found for each product on its corresponding product page